ArticleLeukemia2020

Synthetic lethal targeting of TET2-mutant hematopoietic stem and progenitor cells (HSPCs) with TOP1-targeted drugs and PARP1 inhibitors.

Chang-Bin Jing et al.PubMed ↗Publisher ↗

No numbers read from the abstract.